Catalyst Wire Dossier Catalyst Wire Dossier

Entelon 150 mg

unknown · Hanlim Pharm. Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Entelon 150 mg, covering 2019-06-24 to 2019-06-24. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of the Efficacy and Safety of Entelon Tab. 150mg in Patients With Osteoarthritis of Knee [Phase 3]

See pricing